Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Different Forms News

Page 2 - Different Forms News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Different Forms. Real-time updates on events, politics, business and more.

Eisai Presents New LEQEMBI® (lecanemab-irmb) Investigational Subcutaneous Formulation Interim Study Results and Clinical Improvement Data in Earlier Stages of Early Alzheimer's Disease From Additional Analyses of Clarity AD at The Clinical Trials On Alzheimer's Disease (CTAD) Conference

October 25, 2023
Investigational Subcutaneous Formulation Clears 14% More Plaque Than IV, Pharmacokinetics (AUC) 11% Higher, And Similar ARIA Rates To IV
South Korea United Kingdom United States New Zealand Great Britain Tiff Macklem
Source: financialpost.com

Eisai Presents New LEQEMBI® (lecanemab-irmb) Investigational Subcutaneous Formulation Interim Study Results and Clinical Improvement Data in Earlier Stages of Early Alzheimer's Disease From Additional Analyses of Clarity AD at The Clinical Trials On Alzheimer's Disease (CTAD) Conference - Biogen (NASDAQ:BIIB)

October 25, 2023
Investigational Subcutaneous Formulation Clears 14% More Plaque Than IV, Pharmacokinetics (AUC) 11% Higher, And Similar ARIA Rates To IV 76% Of Patients Showed No Decline And 60% Showed Clinical Improvement At 18
United States South Korea United Kingdom Great Britain Tsujim Protofibrils Haruo Naito
Source: benzinga.com

How to Become an Instagram Influencer Marketer

August 31, 2023
Are you dreaming of turning your Instagram passion into a thriving career? Do you want to know how to become an influential figure in the world of Instagram marketing? Look no further! In this article, we will guide you through the step-by-step process of becoming an Instagram influencer marketer and leveraging the platform’s immense potential […]
Party Analytics Tools Campaign Effectiveness Community Building Research The Brand Research Audience Defining Your
Source: hapblog.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

EISAI TO PRESENT THE LATEST ALZHEIMER'S DISEASE PIPELINE AND RESEARCH, INCLUDING LECANEMAB AND ANTI-MTBR TAU ANTIBODY E2814, AT THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE (AAIC) 2023

July 11, 2023
/PRNewswire/ -- Eisai Co. Ltd (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that the company will present the latest findings on its...
District Of Columbia United States South Korea United Kingdom New Zealand University College
Source: prnewswire.com

FDA Grants Traditional Approval for LEQEMBI (lecanemab-irmb) for the Treatment of Alzheimer's Disease

July 7, 2023
07.07.2023 - The first and only approved treatment shown to reduce the rate of disease progression and to slow cognitive and functional decline in adults with Alzheimer’s disease The Centers for Medicare & Medicaid Services (CMS) announced broader Medicare ...
United States South Korea United Kingdom New Zealand Great Britain Haruo Naito
Source: wallstreet-online.de

Biogen Inc.: FDA Advisory Committee Votes Unanimously to Confirm the Clinical Benefit of LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer's Disease

June 9, 2023
Peripheral and Central Nervous System Drugs Advisory Committee voted based on data from large global confirmatory Phase 3 Clarity AD clinical trial in patients living with early Alzheimer's disease The
South Korea United States United Kingdom New Zealand Great Britain Christophera Viehbacher
Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science